Portuguese 
English 
Spanish 
5 min of reading 
0 comments 
Appeal filed by manufacturer temporarily suspends agency’s restrictions, while consumers still face doubts about recalled batches, health risk, and safety guidance
Ypê obtained a suspensive effect against the decision of the National Health Surveillance Agency that had imposed restrictions on the manufacturing and commercialization of products suspected of contamination. According to Anvisa, the administrative measure is temporarily suspended after an appeal filed by the company, but the recommendation to consumers remains: do not use the indicated items, for safety.
The information was disclosed by Anvisa itself and confirmed by the manufacturer this Friday (8), after the brand’s products had been recalled from supermarkets. The original decision involved items such as dish soap, concentrated dish soap, liquid laundry detergent, and disinfectants, especially in batches mentioned by the agency ending in 1.
Although the suspensive effect temporarily allows the company to resume the manufacturing and commercialization of the categories affected by Resolution-RE nº 1.834/2026, the situation has not yet concluded. On the contrary: Anvisa informed that the case will be analyzed by the Collegiate Board in the coming days, a stage that should define whether the measures will be maintained, altered, or revoked.
-
Mr. Jayr, at 78 years old, lives high up in the Serra do Condado, where he was born with 13 siblings. He produces milk, makes award-winning artisanal cheeses, and preserves a family tradition marked by hard work, faith, and love for the land.
-
Luciano Hang claims persecution after Havan was notified for using the Brazilian flag on shopping bags.
-
While irregular buildings often challenge residents for decades, neighbors of a condominium in India faced a real estate giant and managed to demolish two 100-meter towers in front of the cameras.
-
A man wins R$ 7 million in the lottery, fails to claim it within the deadline, and loses the right to receive the prize, which ultimately went to another destination.
Suspect Ypê products associated with health risk after factory inspection
According to Anvisa, the products cited in the resolution present a health risk. The decision was made based on a technical evaluation conducted in conjunction with the National Health Surveillance System, SNVS. Furthermore, the analysis occurred after a joint inspection carried out with the Health Surveillance Center of São Paulo, CVS-SP, and the Health Surveillance of Amparo, Visa-Amparo.
During the inspection, carried out last week, significant non-compliances were identified in stages considered critical to the production process. As informed by the agency, the problems involved failures in quality assurance, production, and quality control systems, essential points for the safety of sanitizing products commercialized on a large scale in Brazil.
In this context, Anvisa stated that the irregularities compromise compliance with the requirements of Good Manufacturing Practices, known as GMP. These requirements are mandatory for the production of sanitizing products, precisely because they seek to reduce risks of contamination, control failures, and undue exposure of consumers to undesirable microorganisms.
The most sensitive point of the investigation is the possibility of microbiological contamination. In other words, the unwanted presence of pathogenic microorganisms in the products. Although sanitizing products are used for cleaning, some of them frequently come into contact with surfaces, household utensils, clothes, and shared environments, which increases health concern when there is suspicion of production failure.
The resolution also cites a health inspection carried out at the factory between April 27 and 30. According to inspectors, this inspection found non-compliance with good production practices. Consequently, Anvisa determined control measures, including product recall and restrictions on the manufacturing and commercialization of the indicated categories.
Pseudomonas aeruginosa bacteria reportedly found in samples
According to the director of the Health Surveillance Center of São Paulo, Manoel Lara, the decision to halt production was motivated by the company’s inability to consistently resolve a previously identified problem. The case, as reported by inspectors, was initially noted in November of last year.
On that occasion, the presence of Pseudomonas aeruginosa bacteria was detected in samples of products manufactured last year. This microorganism is not considered highly aggressive for most healthy people but can pose a risk to more vulnerable groups, especially people with low immunity.
Pseudomonas aeruginosa is known to frequently appear in hospital environments and is associated with opportunistic infections. It can primarily affect the lungs and requires special attention in patients with cystic fibrosis, as well as hospitalized or immunosuppressed individuals. Therefore, even if the risk varies according to the consumer’s profile, Anvisa’s preventive recommendation gained weight.
In addition to the detection of the bacteria, inspectors also reported structural and hygiene problems in the inspected unit. The combination of production failures, suspected contamination, and recurrence of the problem led the agency to adopt a tougher stance. However, with the appeal filed by Ypê, the effects of the resolution are suspended pending a new evaluation.
Company appeals, but Anvisa maintains non-use guidance
Ypê announced that it has filed an appeal with Anvisa against the determination to recall some products due to suspected contamination. With this measure, the prohibition on manufacturing and marketing dish soap, concentrated dish soap, liquid laundry detergent, and disinfectants had its effects automatically suspended until a new pronouncement from the agency.
In a statement, the company affirmed that it will continue in constant and permanent dialogue with Anvisa and other authorities. The manufacturer also declared that the appeal aims to present additional clarifications and technical subsidies related to Resolution-RE nº 1.834/2026, published on Thursday.
The company also cited article 17 of Anvisa’s RDC nº 266/2019, according to which the filing of an appeal can automatically suspend the effects of the measure until a new administrative decision. In practice, this means that the restrictions imposed by the agency are temporarily lifted, but they do not annul the investigation or conclude the technical analysis.
On the other hand, Anvisa reinforced that the suspensive effect does not change the consumer safety recommendation. In a note, the agency stated that, even with the appeal underway, it recommends that consumers do not use the indicated products. The guidance was given “for safety” and remains valid until a definitive decision from the Collegiate Board.
The situation also caused doubts among consumers. Many reported difficulty contacting Ypê’s Customer Service on Thursday and Friday to obtain information about recall, exchange, or refund. According to Anvisa’s initial decision, the company should guide consumers on how to return the products included in the measure.
Meanwhile, products were removed from supermarkets this Friday (8), amplifying the repercussion of the case. For the consumer, the scenario is delicate: the company can temporarily resume production and sale of the items, but the regulatory agency maintains the health alert and recommends caution.
Therefore, those who own Ypê products from the cited categories should carefully check the batches indicated by Anvisa, especially those mentioned with a final 1. Until the appeal is judged, the safest recommendation is not to use the suspicious items and to follow new official guidelines regarding any exchange, return, or refund.
With information from: O Globo
Be the first to react!